At a Glance
| BPC-157 | Endorphins | |
|---|---|---|
| Class | Peptide | Neuropeptide |
| Routes | Subcutaneous InjectionOral | |
| Effects | 6 documented | 7 documented |
Dosage
Only in BPC-157
subcutaneous injection
| Level | Dose |
|---|---|
| Threshold | 50 mcg |
| Light | 100–200 mcg |
| Common | 250–500 mcg |
| Strong | 500–750 mcg |
| Heavy | 1000 mcg |
oral
| Level | Dose |
|---|---|
| Threshold | 100 mcg |
| Light | 200–500 mcg |
| Common | 500–1000 mcg |
| Strong | 1000–1500 mcg |
Duration
Only in BPC-157
Effects
Shared Effects2
Unique to BPC-1574
Safety
Interaction: BPC-157 + Endorphins
No direct interaction data available between these substances. This does not mean the combination is safe.
BPC-157 — Dangerous Interactions
No dangerous interactions recorded.
Endorphins — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between BPC-157 and Endorphins?
BPC-157 is classified as a Peptide (Synthetic pentadecapeptide) while Endorphins is classified as a Neuropeptide (Opioid peptide, Neuropeptide). They share 2 effects in common, with 4 effects unique to BPC-157 and 5 unique to Endorphins.
Is it safe to combine BPC-157 and Endorphins?
There is no direct interaction data available for combining BPC-157 and Endorphins. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, BPC-157 or Endorphins?
BPC-157 and Endorphins are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.